Sexually transmitted diseases: Microbiology and management

Journal of Medical Microbiology

Volumn 51, Issue 10, 2002, Pages 793-807

  Birley, H ^a   Duerden, B I ^a   Hart, C A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; METRONIDAZOLE;

ANTIMICROBIAL ACTIVITY; EPIDEMIC; GRAM STAINING; HUMAN; INFECTION CONTROL; MICROBIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SELF HELP; SEXUALLY TRANSMITTED DISEASE; TREATMENT INDICATION; TREATMENT PLANNING; VAGINA FLORA; VAGINITIS; VENEREOLOGY;

EID: 0036800910     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-10-793     Document Type: Review

References (105)

1. World Health Organization/GPA. Policies and Principles for National Programmes for Control of STDs in Developing Countries. WHO, Geneva. 1995.
2. Grosskurth H, Mosha F, Todd J et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomised controlled trial. Lancet 1995; 346: 530-536.
3. World Bank. World Development Report, 1993 Investing in Health. New York, Oxford University Press. 1993.
4. Brabin L, Kemp J, Obunge OK et al. Reproductive tract infections and abortion among adolescent girls in rural Nigeria. Lancet 1995; 345: 300-304.
5. Royal Commission on Venereal Diseases. Final Report of the Commissioners. HMSO, London. 1916.
6. Power D, Murphy JK (eds). A System of Syphilis, Vol 111: Visceral Syphilis. London, Oxford Medical Publ. 1914.
7. Moore JE. Venereology in transition. Br J Vener Dis 1956; 32: 217-225.
8. Hughes G, Simms I, Rogers PA, Swan AV, Catchpole M. New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep CDR Suppl 1998; 8 Suppl 7: S2-S11.
9. The Health of the Nation; Key area handbook. HIV/AIDS and Sexual Health. London, Dept. of Health 1993.
10. Anon. Gonorrhoea incidence in England rises again. Commun Dis Rep CDR Wkly 2000; 10: 107.
11. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
12. Hay PE. Therapy of bacterial vaginosis. J Antimicrob Chemother 1998; 41: 6-9.
13. Blackwell AL, Thomas PD, Wareham K, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993; 342: 206-210.
14. Hay PE, Ugwumadu A, Chowns J. Sex, thrush and bacterial vaginosis. Int J STD AIDS 1997; 8: 603-608.
15. Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis. A newly defined specific infection previously classified "non-specific" vaginitis. Am J Obstet Gynecol 1955; 69: 962-976.
16. Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med 1978; 298: 1429-1434.
17. Rosenstein IJ, Morgan DJ, Sheehan M, Lamont RF, Taylor-Robinson D. Bacterial vaginosis in pregnancy: distribution of bacterial species in different gram-stain categories of the vaginal flora. J Med Microbiol 1996; 45: 120-126.
18. Stanek R, Gain RE, Glover DD, Larsen B. High performance ion exclusion chromatographic characterization of the vaginal organic acids in women with bacterial vaginosis. Biomed Chromatog 1992; 6: 231-235.
19. Thomason JL, Gelbart SM, James JA, Edwards JM, Hamilton PR. Is analysis of vaginal secretions for volatile organic acids to detect bacterial vaginosis of any diagnostic value? Am J Obstet Gynecol 1988; 159: 1509-1511.
20. Cauci S, Monte R, Driussi S, Lanzafame P, Quadrifoglio F. Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis. J Infect Dis 1998; 178: 1698-1706.
21. McGregor JA, French JI, Jones W, Parker R, Patterson E, Draper D. Association of cervicovaginal infections with increased vaginal fluid phospholipase A2 activity. Am J Obstet Gynecol 1992; 167: 1588-1594.
22. Schoonmaker JN, Lunt BD, Lawellin DW, French JI, Hillier SL, McGregor JA. A new proline aminopeptidase assay for diagnosis of bacterial vaginosis. Am J Obstet Gynecol 1991; 165: 737-742.
23. Thomason JL, Gelbart SM, Wilcoski LM, Peterson AK, Jilly BJ, Hamilton PR. Proline aminopeptidase activity as a rapid diagnostic test to confirm bacterial vaginosis. Obstet Gynecol 1988; 71: 607-611.
24. McGregor J-A, French JI, Jones W et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170: 1048-1060.
25. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol 1983; 18: 170-177.
26. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
27. Thomason JL, Anderson RJ, Gelbart SM et al. Simplified gram stain interpretative method for diagnosis of bacterial vaginosis. Am J Obstet Gynecol 1992; 167: 16-19.
28. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308: 295-298.
29. Platz-Christensen JJ, Larsson P-G, Sundström E, Wiqvist N. Detection of bacterial vaginosis in wet mount, Papanicolaou stained vaginal smears and in gram stained smears. Acta Obstet Gynaecol Scand 1995; 74: 67-70.
30. Lamont RF, Hudson EA, Hay PE et al. A comparison of the use of Papanicolaou-stained cervical cytological smears with Gram-stained vaginal smears for the diagnosis of bacterial vaginosis in early pregnancy. Int J STD AIDS 1999; 10: 93-97.
31. Wawer MJ, Sewankambo NK, Serwadda D et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet 1999; 353: 525-535.
32. Larsson P-G. Treatment of bacterial vaginosis. Int J STD AIDS 1992; 3: 239-247.
33. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 1992; 268: 92-95.
34. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 479-482.
35. Hillier SL, Lipinski C, Briselden AM, Eschenbach DA. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gvnecol 1993; 81: 963-967.
36. Colli E, Landoni M, Parazzini F and participants. Treatment of male partners and recurrence of bacterial vaginosis: A randomised trial. Genitourin Med 1997; 73: 267-270.
37. McGregor JA, Roberts AM. First antenatal visits and metronidazole. Am J Obstet Gynecol 1997; 176: 887-888.
38. McGregor JA, French JI, Parker R et al. Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173: 157-167.
39. Joesoef MR, Hillier SL, Wiknjosastro G et al. Intravaginal clindamycin treatment for bacterial vaginosis: Effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995; 173: 1527-1531.
40. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345-349.
41. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732-1736.
42. McDonald HM, O'Loughlin JA, Vigneswaran R et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomised placebo controlled trial. Br J Obstet Gynaecol 1997; 104: 1391-1397.
43. Carey JC, Klebanoff MA, Hauth JC et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342: 534-540.
44. Korn AP, Bolan G, Padian N, Ohm-Smith M, Schachter J, Landers DV. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995; 85: 387-390.
45. Larsson P-G, Platz-Christensen J-J, Thejls H, Forsum U, Påhlson C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Obstet Gynecol 1992; 166: 100-103.
46. Cohen CR, Duerr A, Pruithithada N et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995; 9: 1093-1097.
47. Sewankambo J, Gray RH, Wawer MJ et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 546-550.
48. Taha TE, Hoover DR, Dallabetta GA et al. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 1998; 12: 1699-1706.
49. Catlin BW. Nutritional profiles of Neisseria gonorrhoeae. Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing. J Infect Dis 1973; 128: 178-194.
50. Knapp JS, Tam MR, Nowinski RC, Holmes KK, Sandstrom EG. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein 1. J Infect Dis 1984; 50: 44-48.
51. Gill MJ. Serotyping Neisseria gonorrhoeae: a report of the Fourth International Workshop. Genitourin Med 1991; 67: 53-57.
52. Ison CA, Whitaker L, Renton A. Concordance of auxotype/serovar classes of Neisseria gonorrhoeae between sexual contacts. Epidemiol Infect 1992; 109: 265-271.
53. Gutjahr TS, O'Rourke M, Ison CA, Spratt BG. Arginine-, hypoxanthine-, uracil- requiring isolates of Neisseria gonorrhoeae are a clonal lineage within a non-clonal population. Microbiology 1997; 143: 633-640.
54. Ison CA. Genotyping of Neisseria gonorrhoeae. Curr Opin Infect Dis 1998; 11: 43-46.
55. O'Rourke M, Stevens E. Genetic structure of Neisseria gonorrhoeae populations: A non-clonal population. J Gen Microbiol 1993; 139: 2603-2611.
56. Hunter PR, Gaston MA. Numerical index of discriminatory ability of typing systems: An application of Simpson's index of diversity. J Clin Microbiol 1988; 26: 2465-2466.
57. Roberts MC. Plasmids of Neisseria gonorrhoeae and other Neisseria species. Clin Microbiol Rev 1989; 2 Suppl: S18-S23.
58. O'Rourke M, Ison CA, Renton AM, Spratt BG. Opa-typing: A high resolution tool for studying the epidemiology of gonorrhoea. Mol Microbiol 1995; 17: 865-875.
59. Ward H, Ison CA, Day SE et al. A prospective social and molecular investigation of gonococcal transmission. Lancet 2000; 356: 1812-1817.
60. Yirrell DL, Robertson P, Goldberg DJ, McMenamin J, Camerson S, Leigh Brown AJ. Molecular investigation into outbreak of HIV in a Scottish prison. BMJ 1997; 314: 1446-1450.
61. Tramont EC. Syphilis in adults: from Christopher Columbus to Sir Alexander Fleming to AIDS. Clin Infect Dis 1995; 21: 1361-1369.
62. Akovbian BA, Tikhonova LI, Maskilleison AL, Borisenko K, Prokhorenko B. Syphilis morbidity in Russia: historical experience, epidemiological analysis and anticipated trends. Sex Transm Dis 1995; 4: 15-21.
63. Linglof T. Rapid increase of syphilis and gonorrhoea in parts of the former USSR. Sex Transm Dis 1995; 22: 160-161.
64. Tichonova K, Borisenko H, Ward H, Meheus A, Gromyko A, Renton A. Epidemics of syphilis in the Russian Federation: Trends, origins, and priorities for control. Lancet 1997; 350: 210-213.
65. Drusin LM. Syphilis makes a comeback. Int J STD AIDS 1996; 7: 7-9.
66. Tichonova LI. Epidemiology of sexually transmitted diseases in Russia [in Russian]. Sex Transm Dis 1995; 4: 15-21.
67. Aral SO. The social context of syphilis persistence in the southeastern United States. Sex Transm Dis 1996; 23: 9-15.
68. Kreiss J, Caraël M, Meheus A. Role of sexually transmitted diseases in transmitting human immunodeficiency virus. Genitourin Med 1988; 64: 1-2.
69. Dallabetta G, Diomi MC. Treating sexually transmitted diseases to control HIV transmission. Curr Opin Infect Dis 1997; 10: 22-25.
70. Renton AM, Whitaker L. Using STD occurrence to monitor AIDS prevention. Soc Sci Med 1994; 38: 1153-1165.
71. Garnett GP, Anderson RM. Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond [Biol] 1993; 42: 137-159.
72. Plummer FA, Nagelkerke NJ, Moses S, Ndinya-Achola JO, Bwayo J, Ngugi E. The importance of core groups in the epidemiology and control of HIV-1 infection. AIDS 1991; 5 Suppl 1: S169-S176.
73. Gaspard M. Incomes and living standards in central and eastern Europe and the former Soviet Republics. Paper presented at the NATO Economic Colloquium on Economic Developments in Cooperation Partner Countries from a Sectoral Perspective. Brussels, 30 June-2 July 1993.
74. Anon. The Economist Intelligence Unit: Country Report: Russian Federation fourth quarter, 1995.
75. Gimpelson V Labour market and employment in Russia: Beginning of changes. Paper presented at the NATO Economic Colloquium on Economic Developments in Cooperation Partner Countries from a Sectoral Perspective. Brussels, 30 June-2 July 1993.
76. Anon. Control over Sexually Transmitted Diseases: Order No. 286. Moscow, Ministry of health of the Russian Federation. 1993.
77. Anon. Instruction Manual for the Serodiagnosis of Syphilis. Order No. 1161. Moscow, Ministry of Health of the USSR. 1985.
78. Anon. Treatment and Prevention of Syphilis: Recommended Methods. Moscow, Ministry of Health of the Russian Federation. 1993.
79. Carter JS, Bowden FJ, Bastian I, Myers GM, Sripakash KS, Kemp DJ. Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb. nov. Int J Syst Bacteriol 1999; 49: 1695-1700.
80. Carter J, Hutton S, Sriprakash KS et al. Culture of the causative organism of donovanosis (Calymmatobacterium granulomatis) in HEp-2 cells. J Clin Microbiol 1997; 35: 2915-2917.
81. Kharsany AB, Hoosen AA, Kiepiela P, Naicker T, Sturm AW. Growth and cultural characteristics of Calymmatobacterium granulomatis - The aetiological agent of granuloma inguinale (Donovanosis). J Med Microbiol 1997; 46: 597-585.
82. Carter J, Bowden FJ, Sriprakash KS, Bastian I, Kemp DJ. Diagnostic polymerase chain reaction for donovanosis. Clin Inject Dis 1999; 28: 1168-1169.
83. Mein JK, Anstey NM, Bowden FJ. Missing the diagnosis of donovanosis in northern Australia. Med J Aust 1999; 170: 48.
84. Paterson DL. Disseminated donovanosis (granuloma inguinale) causing spinal cord compression: Case report and review of donovanosis involving bone. Clin Infect Dis 1998; 26: 379-383.
85. Govender D, Naidoo K, Chetty R. Granuloma inguinale (donovanosis): An unusual case of otitis media and mastoiditis in children. Am J Clin Pathol 1997; 108: 510-514.
86. Anon. National guideline for the management of donovanosis (granuloma inguinale). Sex Transm Infect 1999; 75 Suppl 1: S38-S39.
87. Bowden FJ, Mein J, Plunkett C, Bastian I. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med 1996; 72: 17-19.
88. Mein J, Bastian I, Guthridge S, Farmer B, Bowden F. Donovanosis: sequelae of severe disease and successful azithromycin treatment. Int J STD AIDS 1996; 7: 448-451.
89. Bowden FJ, Savage J. Donovanosis treatment with azithromycin. Int J STD AIDS 1998; 9: 61-62.
90. Bowden FJ, Savage J. Is the eradication of donovanosis possible in Australia? Aust NZ J Public Health 1998; 22: 7-9.
91. Vogel LC, Richens J. Donovanosis in Dutch South New Guinea: history, evolution of the epidemic and control. PNG Med J 1989; 32: 203-218.
92. Gelfand M, Ross CMD, Blair DM, Castle WM, Weber MC. Schistosomiasis of the male pelvic organs: severity of infection as determined by digestion of tissue and histologic methods in 300 cadavers. Am J Top Med Hyg 1970; 19: 779-784.
93. Leutscher P, Ramarokoto C-E, Reimert C, Feldmeer H, Esterre P, Vennervald BJ. Community-based study of genital schistosomiasis in men from Madagascar. Lancet 2000; 355: 117-118.
94. Kjetland EF, Poggensee G, Gelling-Giese G et al. Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi. Acta Trop 1996; 62: 239-255.
95. Corachan M, Valls ME, Gascon J, Almeda J. Vilana R. Hematospermia: a new etiology of clinical interest. Am J Trop Med Hyg 1994; 50: 580-584.
96. Ganley Y, Beeching N, Wyatt G, Bailey WJ. Semen microscopy in the diagnosis of schistosomiasis infection in returning travellers. Abstract 261, Fifth International Conference on Travel Medicine, Geneva, 1997.
97. Wijers DJB, McMahon JE. Early signs and symptoms of bancroftian filariasis in males at the East African coast. E Afr Med J 1976; 53: 57-63.
98. World Health Organization. Lymphatic Filariasis: The Disease and its Control. Technical Report Series 821. Geneva, WHO. 1992.
99. Burnham G. Onchocerciasis. Lancet 1998; 351: 1341-1346.
100. Karavanjala DK. Filariasis and dracontiasis. In: Husain I (ed) Tropical Urology and Renal Disease. Edinburgh, Churchill Livingstone. 1984: 283-295.
101. Gorse RJ, Belshe RB. Male genital tuberculosis: A review of the literature with illustrative case reports. Rev Infect Dis 1985; 7: 511-524.
102. Gow JG. Genitourinary tuberculosis. In: Schlossenberg D (ed) Tuberculosis, 4th Edn. Philadelphia, Saunders. 1999.
103. Schmid ML, McKendrick MW, Lobo A, Leach M. A perianal ulcer. Lancet 1999; 353: 894.
104. Service MW. Medical entomology for students, 2nd edn. Cambridge, Cambridge University Press. 2000.
105. Gilles HM. Soil-transmitted helminths (geohelminths). In: Cook GC (ed) Manson's Tropical Diseases, 20th Edn. London,Saunders. 1996: 1369-1412.